Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients
Judith Abarca‐Zabalía(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Laura Espino‐Paisán(Hospital Clínico San Carlos)
Cited by 9
Related Papers
Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients
|Experimental Eye Research|2020|49
Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease
|Pharmacological Research|2019|39
Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration
|Nutrients|2019|29
Variations in Circulating Active MMP-9 Levels during Renal Replacement Therapy
|Biomolecules|2020|10